These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35100601)

  • 1. Post-Systemic Chemotherapy Prognoses of Recurrent/Metastatic Soft Tissue Sarcoma Patients with Retroperitoneal/Intra-Abdominal Origin versus Those with Extremities/Trunk Origin.
    Nakano K; Fukuda N; Sato Y; Urasaki T; Ohmoto A; Wang X; Hayashi N; Suto H; Udagawa S; Oki R; Yunokawa M; Ono M; Tomomatsu J; Minami Y; Hayakawa K; Tanizawa T; Ae K; Matsumoto S; Takahashi S
    Oncology; 2022; 100(4):238-246. PubMed ID: 35100601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of treatment patterns among recurrent/metastatic soft tissue sarcoma patients who consulted medical oncologists in Japan.
    Nakano K; Ae K; Matsumoto S; Takahashi S
    J Orthop Sci; 2019 Nov; 24(6):1081-1087. PubMed ID: 31447093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of anatomic location on outcomes in patients with localized primary soft tissue sarcoma.
    Zhao R; Yu X; Feng Y; Wang J; Mao Y; Yin W; Zhang Z; Guo X; Ma S
    Jpn J Clin Oncol; 2018 Sep; 48(9):799-805. PubMed ID: 30060202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcome after hyperthermic isolated limb perfusion for primarily unresectable versus locally recurrent soft tissue sarcoma of extremities.
    Vassos N; Brunner M; Perrakis A; Göhl J; Grützmann R; Hohenberger W; Croner RS
    Surg Oncol; 2020 Dec; 35():162-168. PubMed ID: 32882523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amputation in patients with extremity soft tissue sarcoma: the experience of an East Asian referral center.
    Kim Y; Kim HS; Han I
    BMC Cancer; 2024 Jan; 24(1):61. PubMed ID: 38212719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study.
    Boye K; Lobmaier I; Kobbeltvedt MR; Thorkildsen J; Taksdal I; Bjerkehagen B; Bruland ØS; Zaikova O; Sundby Hall K; Hompland I
    Acta Oncol; 2022 Jul; 61(7):793-800. PubMed ID: 35698755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of residual disease after "unplanned excision" of primary localized adult soft tissue sarcoma of the extremities: evaluation of 452 cases at a single Institution.
    Bianchi G; Sambri A; Cammelli S; Galuppi A; Cortesi A; Righi A; Caldari E; Ferrari S; Donati D
    Musculoskelet Surg; 2017 Dec; 101(3):243-248. PubMed ID: 28444540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastases to the retroperitoneum in patients with extremity soft tissue sarcoma: an unusual metastatic pattern.
    Lev-Chelouche D; Nakache R; Soffer D; Merimsky O; Klausner MJ; Gutman M
    Cancer; 2000 Jan; 88(2):364-8. PubMed ID: 10640969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
    Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
    J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
    Devadas SK; Banavali S
    Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
    von Mehren M; Kane JM; Agulnik M; Bui MM; Carr-Ascher J; Choy E; Connelly M; Dry S; Ganjoo KN; Gonzalez RJ; Holder A; Homsi J; Keedy V; Kelly CM; Kim E; Liebner D; McCarter M; McGarry SV; Mesko NW; Meyer C; Pappo AS; Parkes AM; Petersen IA; Pollack SM; Poppe M; Riedel RF; Schuetze S; Shabason J; Sicklick JK; Spraker MB; Zimel M; Hang LE; Sundar H; Bergman MA
    J Natl Compr Canc Netw; 2022 Jul; 20(7):815-833. PubMed ID: 35830886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy.
    Charlson J
    Curr Treat Options Oncol; 2018 Oct; 19(12):65. PubMed ID: 30361919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
    Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
    Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity : a retrospective analysis.
    Canter RJ; Qin LX; Downey RJ; Brennan MF; Singer S; Maki RG
    Cancer; 2007 Nov; 110(9):2050-60. PubMed ID: 17828771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated limb infusion for advanced soft tissue sarcoma of the extremity.
    Moncrieff MD; Kroon HM; Kam PC; Stalley PD; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2008 Oct; 15(10):2749-56. PubMed ID: 18648882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting prognosis and treatment strategies in metastatic soft tissue sarcomas: twenty years of experience.
    İlhan A; Eraslan E; Yildiz F; Arslan ÜY; Alkiş N
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6465-6472. PubMed ID: 34787850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial intervention chemotherapy for sarcoma and cancerous ulcer via an implanted pump.
    Liu C; Cui Q; Guo J; Li D; Zeng Y
    Pathol Oncol Res; 2014 Apr; 20(2):229-34. PubMed ID: 24446082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments.
    Wagner MJ; Amodu LI; Duh MS; Korves C; Solleza F; Manson SC; Diaz J; Neary MP; Demetri GD
    BMC Cancer; 2015 Mar; 15():175. PubMed ID: 25885530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.